GLP-1 drugs are the latest catalysts feeding demand for healthier snacks. Rivalz uses AI to reimagine snacks in an industry dominated by big players and for consumers with established snacking habits. -------- More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: Visit for business news & analysis, up-to-the-minute market data, features, profiles and more. Connect with Bloomberg Television on: X: Facebook: Instagram: Connect with Bloomberg Business on: X: Facebook: Instagram: TikTok: Reddit: LinkedIn: More from Bloomberg: Bloomberg Radio: Bloomberg Surveillance: Bloomberg Politics: Bloomberg Originals: Watch more on YouTube: Bloomberg Technology: Bloomberg Originals: Bloomberg Quicktake: Bloomberg Espanol: Bloomberg Podcasts: |
Mastercard (MA) Economics Institute shar...
History of the @Goodyear Blimp: “Think o...
The biggest part of sports betting is ‘a...
GLP-1 drugs are the latest catalysts fee...
Over a quarter of Americans (27%) are re...
How tariffs, immigration, and stagflatio...
Ethiopia is scheduled to open its brand ...
The energy crisis facing Ecuador could g...
----------------------------------------...
"I realized early on we couldn't provide...
A lot of homes in being destroyed in the...
The United States military offers an exp...
Under Brian Moynihan's leadership, Bank ...
----------------------------------------...
At #CES2025, Pebble revealed its all-ele...